Integrating chronic pain management into care for patients with opioid use disorder
Grant K, Butterfield M, Bach P., CMAJ. 2025
Early experiences and impacts of a fentanyl powder safer supply program in Vancouver, Canada: a qualitative study
Ivsins A, Sutherland C, Kerr T, Kennedy MC., Am J Drug Alcohol Abuse. 2025
Reimagining subjectivities in place: Necropolitical logics of safer supply and housing in Vancouver’s Downtown Eastside
Fleming T, Boyd J, McNeil R. Soc Sci Med. 2025
Road to recovery: A strategy to meaningfully address British Columbia’s substance use system of care
A. Wellar B. Dennis, MBBS, PhD S. Partridge, MSW R. Brar, MD H. Johnson (sɛƛakəs), MHA C. Johnson, RN, MPH S. Nolan, MD, B C Med J, 2025
Changes in the Sex/Gender Gap in Cannabis Use in Ontario, Canada From 2001 to 2019
Matheson, J., Yeshambel, N., Elton-Marshall, T., Rueda, S., Ali, F., Hamilton, H.A., Rehm, J., Le Foll, B., Imtiaz, S., Drug and Alcohol Review
Five‑Year Outcomes of a School‑Based Personality‑Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial
Patricia Conrod, Sherry H. Stewart, Jean Séguin, Robert Pihl, Benoit Masse, Sean Spinney, Samantha Lynch, American Journal of Psychiatry, 2025
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis
Bastien G, McAnulty C, Sharafi H, Mahroug A, Elkrief L, Ziegler D, Dubreucq S, Juteau LC, Jutras-Aswad D., J Addict Med. 2025
Experiences of stigmatization among people who use drugs in the initial year of British Columbia’s drug decriminalization policy: A qualitative study
Ali, F., Russell, C., Torres-Salback, S., Lo, M., Bonn, M., Bardwell, G., Budau, J., Hyshka, E., Rehm, J., International Journal of Drug Policy
Differences in overdose rates by gender at supervised consumption services: an explanatory sequential mixed methods study
Muel, E., Fan, E., Ginn, C., & Jackson, J., Drugs: Education, Prevention and Policy
Facilitating access to supervised smoking facilities: a qualitative study
Wettemann C, Morgan J, Taylor T, Boll A, Maxwell S, Richardson L, Nolan S, van Draanen J., Harm Reduct J. 2025
